Immunovant (IMVT)

Immunovant (IMVT) stock research: performance, analysts' price targets, earnings, revenue and margins, technicals and insider trades.

• IMVT last traded at $28.88, -0.99% on the day.
• Immunovant: market cap $6.03B, P/E -10.2, next earnings 2026-11-09.
• Over the past year IMVT returned 16.36%; year to date 13.61%.

Updated 2026-11-02 19:17 UTC